Why the study?
Evidence is conflicting regarding the association between atrial fibrillation pattern and ischemic event risk, prompting investigation into whether left atrial diameter affects cardiovascular risk across AF patterns.
Does increased left atrial diameter predict cardiovascular events and mortality in patients with non-valvular atrial fibrillation regardless of AF pattern?
Does increased left atrial diameter predict cardiovascular events and mortality in patients with non-valvular atrial fibrillation regardless of AF pattern?
Answers are grounded in this paper and cite their sources.
Left atrial diameter provides independent prognostic information for cardiovascular events and mortality in non-valvular AF patients, whereas AF pattern itself does not.
BACKGROUND: There are conflicting evidence on the association between atrial fibrillation (AF) pattern, such as persistent/permanent (Pers/Perm) and paroxysmal (PAF) AF and risk of ischemic events. We investigated if left atrial diameter (LAd) may affect the risk of cardiovascular outcomes according to AF pattern. METHODS: Prospective multicenter observational including 1,252 non-valvular AF patients (533 PAF and 719 Pers/Perm AF). Study endpoints were cardiovascular events (CVEs), major adverse cardiac events (MACE) and CV death. LA anteroposterior diameter (LAd) was obtained by transthoracic echocardiography. RESULTS: Pers/Perm AF patients had a higher proportion of LAd above median than PAF (≥44 mm, 59.5% vs 37.5% respectively, P < .001). In a mean follow-up of 42.2 ± 31.0 months (4,315 patients/year) 179 CVEs (incidence rate [IR] 4.2%/year), 133 MACE (IR 3.1%/year), and 97 CV deaths (IR 2.2%/year) occurred. Compared to patients with LAd below median, those with LAd above the median had a higher rate of CVEs (log-rank test, P < .001), MACE (log-rank test P < .001), and CV death (log-rank test P < .001). Multivariable Cox regression analysis showed that LAd above the median was associated with CVEs, (HR 1.569, 95% CI 1.129-2.180, P = .007) MACE (HR 1.858, 95% CI 1.257-2.745, P = .002) and CV death (HR 2.106, 95% CI 1.308-3.390, P = .002). The association between LAd and outcomes was evident both in PAF and Pers/Perm AF patients. No association between AF pattern and outcomes was found. CONCLUSION: LAd is a simple parameter that can be obtained in virtually all AF patients and can provide prognostic information on the risk of CVEs, MACE and CV death regardless of AF pattern.
No takes yet. Share an insight, caveat, or question.
Menichelli et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: